drugset / Trial / NCT00180713

Simvastatin as a Treatment for Pulmonary Hypertension

NCT00180713

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to investigate the safety and efficacy of adding simvastatin to the current conventional treatment regimen for the management of pulmonary hypertension.

Timeline

Start
2005-10
Primary completion
2008-10
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 80 mg